Press Releases

 Filter by Provider

BlueLinx Holdings Inc. (NYSE: BXC), a leading U.S. wholesale distributor of building products, today reported financial results for the fiscal three months ended July 4, 2026 (“second quarter 2026”).

IonQ (NYSE: IONQ), a leading quantum platform company, today announced it has signed a memorandum of understanding with Sandia National Laboratories, to explore accelerated co-design of quantum information science technologies in support of U.S. national security innovation.

Revenue up 23% QoQ. Contribution Profit up 59% QoQ. Contribution Margin up 140bps both QoQ and YoY. Homes purchased up 77% QoQ and 149% YoY. Inventory Health Improved 1% QoQ and 27% YoY. Combined Marketing and Operations per acquisition contract lowest in Company history1. Opendoor to be ANI positive on a twelve-month go-forward basis at the end of 2026.

EL MONTE, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B technology solutions for large parcel merchandise, today announced that Erica Wei, its Chief Financial Officer, will conduct one-one-one virtual meetings with investors at Oppenheimer’s 29th Annual Technology, Internet & Communications conference on Tuesday, August 11, 2026.

LOS ANGELES, Aug. 04, 2026 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL), today announced financial results for the second quarter ended June 30, 2026.

Second Quarter 2026 Financial Highlights:

WASHINGTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Ionic Digital Inc. (Nasdaq: IOND) (“Ionic Digital”) today announced that Chief Executive Officer Andy Stewart and Chief Financial Officer Chris Hickman are scheduled to participate in Canaccord Genuity’s 46th Annual Growth Conference on August 12, 2026 in Boston, Massachusetts.

Record Second Quarter Revenue of $304 Million, Up 24% YoY

Net sales increased 11.6% year-over-year to $83.9 million

New York, NY, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Chaince Securities, LLC (“Chaince”), a FINRA-registered broker-dealer and wholly owned subsidiary of Chaince Digital Holdings Inc. (NASDAQ: CD), today announced that it has been engaged as exclusive sales agent for the at-the-market (“ATM”) equity offering program of ZJK Industrial Co., Ltd. (NASDAQ: ZJK) (“ZJK Industrial” or the “Company”), a high-tech enterprise specializing in the manufacturing and sale of precision fasteners, structural parts and other precision metal parts. The engagement is made pursuant to an At Market Sales Agreement dated [●], 2026 (the “Sales Agreement”), under which the Company may offer and sell, from time to time, Class A ordinary shares through Chaince.

Over 3.1 million Paid Subscribers, up 3% over Q2 2025  

Second Quarter 2026 Revenue Surpasses $70 million for the First Time in Company History, and Increased 15% Year-over-Year

Second quarter total revenue of $214 million, Crysvita® revenue of $156 million and Dojolvi® revenue of $27 million

SCHAUMBURG, Ill., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Paylocity Holding Corporation (Nasdaq: PCTY), a leading cloud-based provider of HCM, finance and IT software solutions, today announced financial results for the fourth quarter and fiscal 2026, which ended June 30, 2026.

 - Net Income of $0.15 Per Diluted Share - - Increased 2026 AFFO Guidance $0.01 to $1.41 - $1.43 Per Diluted Share, Representing Growth of 7.6% Year-Over-Year at the Midpoint -- Increased 2026 Acquisition Guidance $20 Million to $150 Million - $160 Million -- $38.5 Million of Gross Equity Sales via ATM Program in Second Quarter - - Acquired 37 USPS Properties for $45.1 Million at a Weighted Average Capitalization Rate of 7.3% -

WALTHAM, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Crane NXT, Co. (NYSE: CXT), a global leader in authentication and traceability technologies, today announced that Aaron Saak, President and Chief Executive Officer, and Christina Cristiano, Senior Vice President and Chief Financial Officer, will participate in a fireside chat at the Oppenheimer 29th Annual Technology, Internet & Communications Conference on Tuesday, August 11, 2026 at 2:05 p.m. ET. 

SAN JOSE, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today reported unaudited financial results for the quarter ended June 30, 2026.

SAN DIEGO, Aug. 04, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine ophthalmologic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia in adults, today announced that it will host a webcast on Tuesday, August 11, 2026, at 4:30 p.m. EDT to report its second quarter 2026 financial results and recent corporate highlights.

MOUNTAIN VIEW, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to release financial results for the second quarter 2026 and provide a business update after the close of trading on August 18, 2026.

NEWARK, CA / ACCESS Newswire / August 4, 2026 / Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on July 31, 2026, it granted inducement awards to two recently hired employees in accordance with the terms of their employment offer letters. The awards were granted under the Protagonist Therapeutics Amended and Restated Inducement Plan, which was adopted May 29, 2018, and amended February 18, 2020 and February 15, 2022.

Investor Conference Call to be conducted on the same day at 4:30 p.m. Eastern

WINTER PARK, Fla., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ: STEX), a technology company building the future of the commodity markets through tokenization, today announced that it will release its financial results for the second quarter on Friday August 14, 2026, and host a corresponding earnings and corporate update presentation on Monday, August 17, 2026, at 4:30 p.m. ET.

The actual purification effect of the faucet with purification function can be tested from many aspects such as water quality index detection, purification effect stability detection, health and safety detection. The following is the specific detection method:

Second Quarter Net Income Increases 28% from $7.9 Million to $10.1 Million

NextNav Inc. (Nasdaq: NN), a leader in next-generation terrestrial Positioning, Navigation, and Timing (PNT) and 3D geolocation solutions, today announced that Chief Financial Officer, Tim Gray, will participate in the following conferences in August 2026:

Insight Enterprises, Inc. (Nasdaq: NSIT) today announced that it is scheduled to participate in the following upcoming investor conference:

KPS Global, a majority-owned company of Viessmann Generations Group, has finalized a strategic partnership agreement with Everidge. The successful completion of the transaction follows the earlier announcement regarding the plan to combine the two complementary businesses.

Niagen Bioscience, Inc. (NASDAQ:NAGE) today announced operational updates and financial results for the second quarter of 2026.

Southfield, Michigan, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) today announced consolidated net income of $135.9 million, or $12.66 per diluted share, for the three months ended June 30, 2026. Adjusted net income, a non-GAAP financial measure, for the three months ended June 30, 2026 was $130.1 million, or $12.12 per diluted share. The following table summarizes our financial results:

Announced positive topline induction data for SPY001 and SPY002 from Part A of the Phase 2 SKYLINE trial (“SKYLINE”), demonstrating best-in-class efficacy potential and a safety profile consistent with in-class comparators 

The pressure on customer experience teams isn't letting up: more interactions, tighter staffing, higher expectations. First quarter results from 8x8, Inc.'s fiscal year 2027 show organizations are responding by deploying AI that reduces interaction volume, meets customers on their preferred digital channels, and consolidates communications on a platform built to scale. Usage-based revenue, which includes communication APIs, AI solutions, digital channels, and telecom, continued its strong growth trajectory from Q4 FY26 with a 63 % year-over-year increase in Q1 FY27.

CHICAGO and VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today reported its financial results for the quarter ended June 30, 2026. Financial results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”), and all currency is in U.S. dollars.

Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leader in test measurement, control and calibration, has reported its financial and operational results for its fiscal first quarter ended June 27, 2026 (the “first quarter”) of fiscal year 2027.

Marriott Vacations Worldwide Corporation (“MVW”) (NYSE: VAC) today announced the appointment of Vladimir “Vlad” Anokhin as Chief Strategy & Transformation Officer. Anokhin reports to Chief Executive Officer Matt Avril and serves as a member of the company's Executive Leadership Team.

Twist Bioscience Corporation (Nasdaq: TWST) (“Twist”), a mid-cap growth and value biotech company, today announced the commencement of an underwritten public offering of $250.0 million of shares of its common stock. In addition, Twist intends to grant the underwriters a 30-day option to purchase up to an additional $37.5 million of shares of its common stock. All of the shares of common stock to be sold in the proposed offering are being offered by Twist. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the proposed offering may be completed, or as to the actual size or terms of the proposed offering.

Bed Bath & Beyond, Inc. (NYSE:BBBY), owner of Bed Bath & Beyond, Overstock, buybuy BABY, the Kirkland’s and Kirkland's Home brands, and more recently The Container Store, Elfa, Closet Works, and SFV Services, as well as a blockchain asset portfolio, today reported financial results for the second quarter ended June 30, 2026.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2026 third quarter ended June 30, 2026. The Company is hosting a conference call today, August 4, 2026, at 4:30 p.m. ET to discuss the results.

Lumen Technologies, Inc. (NYSE: LUMN) today reported second quarter 2026 results demonstrating continued execution against its transformation strategy and progress toward the financial and operational goals outlined at Investor Day. During the quarter, Lumen delivered financial results in line with expectations, continued improving its business revenue mix, advanced simplification initiatives, and strengthened its digital platform strategy for enterprise customers operating in an AI-driven, multi-cloud world.

Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 12,555 shares of the Company’s common stock to four new employees (the “Inducement Grants”) on August 3, 2026 (the “Grant Date”). The Inducement Grants have been granted pursuant to the Company’s 2025 Inducement Plan. The Inducement Grants were granted as an inducement material to these individuals entering into employment with Neurogene in accordance with Nasdaq Listing Rule 5635(c)(4).

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results in combination with a shareholder letter for the second quarter ended July 3, 2026, on Wednesday, August 12, 2026, after the market close. The Company will also host an earnings call and webcast at 5:30 p.m. ET to discuss its financial results and business progress.

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial and operational results for the second quarter ended June 30, 2026, and highlighted recent business accomplishments.

SiteOne® Landscape Supply, Inc. (NYSE: SITE) announced today that its subsidiary, Devil Mountain Wholesale Nursery, has acquired Patterson Nursery Sales. Patterson is a leading grower and distributor of premium Oregon nursery products serving customers coast-to-coast.

OneSpan Inc. (NASDAQ: OSPN) today reported financial results for the second quarter ended June 30, 2026.

Mechelen, Belgium; 04 August 2026, 22.01 CET; regulated information

BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that David Meeker, M.D., Chairman, President and Chief Executive Officer, and Hunter Smith, Chief Financial Officer, will participate in fireside chats at three upcoming conferences.

BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that on August 3, 2026, the Compensation Committee of Praxis’ Board of Directors granted restricted stock unit awards covering an aggregate of 7,318 shares of its common stock to twenty-nine new non-executive employees under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The restricted stock unit awards were granted as inducements material to the employees’ entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4).

Travere Therapeutics, Inc. (Nasdaq: TVTX) today reported its second quarter 2026 financial results and provided a corporate update.

New 141,000-square-foot facility will consolidate operations from three Connecticut sites, strengthening support for critical U.S. Navy programs and positioning the business for growth across the evolving nuclear energy landscape

Advancing a neuromuscular franchise with claseprubart, a highly potent investigational classical pathway inhibitor, with best-in-disease potential across generalized Myasthenia Gravis (gMG), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), and Multifocal Motor Neuropathy (MMN)

Second Quarter Revenue Increased 27.2% Year-over-Year